year 12, Issue 1 (March - April 2018)                   Iran J Med Microbiol 2018, 12(1): 51-60 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jamali B, Jamali S. RETRACTED: Relative Frequency of Human papillomavirus Genotypes and its Related Characteristics in Women Referred to Alzahra Hospital in Tabriz (RETRACTED). Iran J Med Microbiol. 2018; 12 (1) :51-60
1- Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran ,
2- Department of Laboratory Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran
Abstract:   (7019 Views)
According to COPE and IJMM policy this article was retracted. 

Fabrication - Retracted 

 Background and Aims: Human papillomavirus (HPV) is one of the major public health problems and the main causes of cervical cancer. The prevalence HPV infection in developing countries with low financial resources is high. This study aimed to determine the relative frequency of HPV genotypes and its sociodemographic characteristics in women referred to a general hospital in Tabriz, Iran from 2015-2016.
Materials and Methods: This cross-sectional study was performed in 400 women with Pap smear samples, referring to to a general hospital in Tabriz, Iran from 2015- 2016. The detection of 28 HPV genotypes was performed by using the PCR technique. The sociodemographic survey was conducted for each HPV positive woman.
Results: HPV-positive infection was detected in 155 (38.75%) women aged 17-85 years. HPV 16 (19.1%) was the most prevalent type, followed by HPV 39 (12.5%) and HPV 18 (8.9%). The highest rate of HPV infection was observed at the age of 36 years (7.7%). The level of education and economic situation of each woman were showed most of HPV-positive women had a high school diploma (34.6%) and average economic situation (67,9%). 60.9% of these women were a housewife, and 67.3% lived in the capital .
Conclusions: Determination of HPV genotype and risk factor related to HPV infection in each geographical region can lead to the production of effective vaccines against the HPV virus. It can also be useful for disease management and high sensitivity diagnosis of cervical intraepithelial neoplasia.


Fabrication - Retracted 

Full-Text [PDF 790 kb]   (3273 Downloads)    
Type of Study: Original Research Article | Subject: Medical Virology
Received: 2017/10/28 | Accepted: 2018/02/13 | ePublished: 2018/05/14

1. Jamali S , Jamali B. Investigation of the genetic diversity of HPV in cervical cancer. 7th Iranian congress of virology. (10-11may 2017).
2. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:S11-S25. [DOI] [PubMed]
3. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1-17. [DOI] [PubMed]
4. Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789-99. [DOI] [PubMed]
5. Khorasanizadeh F, Hassanloo J, Khaksar N, Taheri SM, Marzaban M, Rashidi BH, et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women—Analyses of national data and systematic review of the literature. Gynecol Oncol. 2013;128(2):277-81. [DOI] [PubMed]
6. Yousefzadeh A, Mostafavizadeh SM, Jarollahi A, Raeisi M, Garshasbi M, Siavashvahabi Z, et al. Human papillomavirus (HPV) prevalence and types among women attending regular gynecological visit in Tehran, Iran. Clin Lab. 2014;60(2):267-73. [DOI]
7. Giorgi Rossi P, Baldacchini F, Ronco G. The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Front Oncol. 2014;4:20. [DOI] [PubMed]
8. Möbius G. Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J Cancer Res Clin Oncol. 1993;119(9):513-21. [DOI] [PubMed]
9. Bashizadeh-Fakhar H, Ghane M, Faraji R, Ashoorizadeh B. Identifying Human Papilloma Virus (HPV) in Women with Genital Warts by Multiplex– PCR Method. ZJRMS. 2013;15(10):45-8.
10. Sigaroodi A, Nadji SA, Naghshvar F, Nategh R, Emami H, Velayati AA. Human papillomavirus is associated with breast cancer in the north part of Iran. Sci World J. 2012;2012.
11. Nadji SA, Mokhtari-Azad T, Mahmoodi M, Yahyapour Y, Naghshvar F, Torabizadeh J, et al. Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer lett. 2007;248(1):41-6. [DOI] [PubMed]
12. Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis. 2010;43(1):64-9. [DOI] [PubMed]
13. Allameh T, Moghim S, Farahbod F. Reviewing the Prevalence of Human Papillomavirus (HPV) in Married Women Aged 18-60 Years with Normal Pap Smear Referring to Gynecology Clinics in Hospitals Affiliated to Isfahan University of Medical Sciences, Iran. J Isfahan Medl School. 2012;29(163).1-8.
14. Clifford G, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63-73. [DOI] [PubMed]
15. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol 2006;103(1):12-7. [DOI] [PubMed]
16. Salehi-Vaziri M, Sadeghi F, Hashemi FS, Haeri H, Bokharaei-Salim F, Monavari SH, et al. Distribution of Human Papillomavirus genotypes in Iranian women according to the severity of the cervical lesion. Iran Red Crescent Med J. 2016;18(4):e24458. [DOI] [PubMed]
17. Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care. 2006;12(17 Suppl):S462-72. [PubMed]
18. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1808-16. [DOI] [PubMed]
19. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol. 2009;(3 Suppl):S15-23. [DOI] [PubMed]
20. Rossi PG, Baldacchini F, Ronco G. The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Frontiers Oncol. 2014;4:20.
21. Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, et al. Examining the association between socioeconomic status and potential human papillomavirus‐associated cancers. Cancer. 2008;113(10 Suppl):2910-8. [DOI] [PubMed]
22. Smith E, Johnson S, Ritchie J, Feddersen D, Wang D, Turek L, et al. Persistent HPV infection in postmenopausal age women. Int J Gynecol Obstet. 2004;87(2):131-7. [DOI] [PubMed]
23. Halimi L, Haghdoost AA, Alizadeh SM. Prevalence of cigarette smoking among Iranian women: a systematic review and meta-analysis. Med J Islam Repub Iran. 2013;27(3):132-40. [PubMed]
24. Kumar R, Rai AK, Das D, Das R, Kumar RS, Sarma A, et al. Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: Study from North-East Region of India. PloS One. 2015;10(10):e0140700. [DOI] [PubMed]
25. Dimitrov G, Džikova E, Dimitrov G, Babushku G, Antovska V. The influence of HPV16,smoking and coitarche in the development of cervical dysplasia in the stage where conization is the treatment of choice. Acta Facult Med Naissens. 2012;29(4):181-6.
26. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12-F23. [DOI] [PubMed]
27. Catarino R, Vassilakos P, Tebeu P-M, Schäfer S, Bongoe A, Petignat P. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women. Cancer Epidemiol. 2016;40:60-6. [DOI] [PubMed]
28. Allan BR, Marais DJ, Denny L, Hoffman M, Shapiro S, Anna-Lise W. The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus. S Afr Med J. 2006;96(11):1186-90. [PubMed]
29. Kornegay JR, Roger M, Davies PO, Shepard AP, Guerrero NA, Lloveras B, et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol. 2003;41(3):1080-6. [DOI] [PubMed]
30. Soper D. Reducing the health burden of HPV infection through vaccination. Infect Dis Obstet Gynecol. 2006;2006: 83084. [DOI] [PubMed]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc